Antineoplastics 4 Flashcards

0
Q

Catalyzes hydrolysis of L-asparagine to asp acid and ammonia

A

Asparaginase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Enzymes and enzyme inhibitors

A

Asparaginase

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hepatotox

CNS depression

A

Asparaginase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most sensitive cells to asparaginase

A

Lymphoblasts in ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antimitotic, delays transit of cells through s phase, arrest in late s or early g2

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bone marrow tox, podophyllin derivative

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Testicular cancer, hodgkins, lung cancer

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stimulates dna topoisomerase ii to cleave dna

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Monoclonal antibodies

A

Trastuzumab
Rituximab
Bevacizumab
Cetuximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Downreg of HER2 receptor, dec angiogenesis

A

Trastuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Against CD20 antigen

A

Rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antiangigenesis, attaches to and stops vegf, usually used with 5FU

A

Bevacizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Targets EGF, used with irinotecan

A

Cetuximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Colorectal cancer

A

Cetuximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metastatic colorectal cancer

A

Bevacizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

B cell non hodgkin lymphoma, post transplant lymphoma, CLL

A

Rituximab

16
Q

Breast cancer

A

Trastuzumab

17
Q

Outcome of chemotherapy (5)

A
Tumor size
Tumor heterogeneity 
Organs involved and location of tumor
Pharmacologic factors
Host factors